Suppr超能文献

重新审视社会分子病理学流行病学:精准医学新时代的分子病理学流行病学与社会科学的融合。

Revisiting social MPE: an integration of molecular pathological epidemiology and social science in the new era of precision medicine.

机构信息

Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, United States.

California Center for Population Research, University of California, Los Angeles, CA United States.

出版信息

Expert Rev Mol Diagn. 2021 Sep;21(9):869-886. doi: 10.1080/14737159.2021.1952073. Epub 2021 Jul 26.

Abstract

INTRODUCTION

Molecular pathological epidemiology (MPE) is an integrative transdisciplinary area examining the relationships between various exposures and pathogenic signatures of diseases. In line with the accelerating advancements in MPE, social science and its health-related interdisciplinary areas have also developed rapidly. Accumulating evidence indicates the pathological role of social-demographic factors. We therefore initially proposed social MPE in 2015, which aims to elucidate etiological roles of social-demographic factors and address health inequalities globally. With the ubiquity of molecular diagnosis, there are ample opportunities for researchers to utilize and develop the social MPE framework.

AREAS COVERED

Molecular subtypes of breast cancer have been investigated rigorously for understanding its etiologies rooted from social factors. Emerging evidence indicates pathogenic heterogeneity of neurological disorders such as Alzheimer's disease. Presenting specific patterns of social-demographic factors across different molecular subtypes should be promising for advancing the screening, prevention, and treatment strategies of those heterogeneous diseases. This article rigorously reviewed literatures investigating differences of race/ethnicity and socioeconomic status across molecular subtypes of breast cancer and Alzheimer's disease to date.

EXPERT OPINION

With advancements of the multi-omics technologies, we foresee a blooming of social MPE studies, which can address health disparities, advance personalized molecular medicine, and enhance public health.

摘要

简介

分子病理流行病学(MPE)是一个综合的跨学科领域,研究各种暴露与疾病的致病特征之间的关系。随着 MPE 的加速发展,社会科学及其与健康相关的跨学科领域也迅速发展。越来越多的证据表明社会人口因素具有病理性作用。因此,我们在 2015 年首次提出了社会 MPE,旨在阐明社会人口因素的病因作用,并解决全球的健康不平等问题。随着分子诊断的普及,研究人员有充分的机会利用和发展社会 MPE 框架。

涵盖领域

乳腺癌的分子亚型已被严格研究,以了解其源于社会因素的病因。新出现的证据表明,阿尔茨海默病等神经退行性疾病存在发病异质性。在不同的分子亚型中呈现出特定的社会人口因素模式,这对于推进这些异质疾病的筛查、预防和治疗策略应该是有希望的。本文严格回顾了迄今为止关于乳腺癌和阿尔茨海默病的分子亚型中种族/民族和社会经济地位差异的文献。

专家意见

随着多组学技术的进步,我们预计社会 MPE 研究将会蓬勃发展,这将有助于解决健康差距、推进个性化分子医学和加强公共卫生。

相似文献

1
Revisiting social MPE: an integration of molecular pathological epidemiology and social science in the new era of precision medicine.
Expert Rev Mol Diagn. 2021 Sep;21(9):869-886. doi: 10.1080/14737159.2021.1952073. Epub 2021 Jul 26.
2
Integration of molecular pathology, epidemiology and social science for global precision medicine.
Expert Rev Mol Diagn. 2016;16(1):11-23. doi: 10.1586/14737159.2016.1115346. Epub 2015 Dec 4.
4
Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.
J Gastroenterol. 2017 Mar;52(3):265-275. doi: 10.1007/s00535-016-1272-3. Epub 2016 Oct 13.
5
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease.
Mod Pathol. 2013 Apr;26(4):465-84. doi: 10.1038/modpathol.2012.214. Epub 2013 Jan 11.
7
Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology.
Annu Rev Pathol. 2019 Jan 24;14:83-103. doi: 10.1146/annurev-pathmechdis-012418-012818. Epub 2018 Aug 20.
8
Molecular pathological epidemiology gives clues to paradoxical findings.
Eur J Epidemiol. 2015 Oct;30(10):1129-35. doi: 10.1007/s10654-015-0088-4. Epub 2015 Oct 7.
9
Proceedings of the second international molecular pathological epidemiology (MPE) meeting.
Cancer Causes Control. 2015 Jul;26(7):959-72. doi: 10.1007/s10552-015-0596-2. Epub 2015 May 9.
10
Proceedings of the third international molecular pathological epidemiology (MPE) meeting.
Cancer Causes Control. 2017 Feb;28(2):167-176. doi: 10.1007/s10552-016-0845-z. Epub 2017 Jan 17.

引用本文的文献

1
Immune Checkpoint Molecules: A Review on Pathways and Immunotherapy Implications.
Immun Inflamm Dis. 2025 Apr;13(4):e70196. doi: 10.1002/iid3.70196.
2
Is early-onset cancer an emerging global epidemic? Current evidence and future implications.
Nat Rev Clin Oncol. 2022 Oct;19(10):656-673. doi: 10.1038/s41571-022-00672-8. Epub 2022 Sep 6.
3
Proceedings of the fifth international Molecular Pathological Epidemiology (MPE) meeting.
Cancer Causes Control. 2022 Aug;33(8):1107-1120. doi: 10.1007/s10552-022-01594-7. Epub 2022 Jun 27.

本文引用的文献

1
Role and potential clinical utility of ARID1A in gastrointestinal malignancy.
Mutat Res Rev Mutat Res. 2021 Jan-Jun;787:108360. doi: 10.1016/j.mrrev.2020.108360. Epub 2020 Dec 4.
3
Opinion: Standardizing gene product nomenclature-a call to action.
Proc Natl Acad Sci U S A. 2021 Jan 19;118(3). doi: 10.1073/pnas.2025207118.
4
Neighborhood Social Environmental Factors and Breast Cancer Subtypes among Black Women.
Cancer Epidemiol Biomarkers Prev. 2021 Feb;30(2):344-350. doi: 10.1158/1055-9965.EPI-20-1055. Epub 2020 Nov 24.
5
Epidemiology and Molecular-Pathologic Characteristics of CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer.
Clin Colorectal Cancer. 2021 Jun;20(2):137-147.e1. doi: 10.1016/j.clcc.2020.09.007. Epub 2020 Oct 12.
6
Rising incidence of early-onset colorectal cancer - a call to action.
Nat Rev Clin Oncol. 2021 Apr;18(4):230-243. doi: 10.1038/s41571-020-00445-1. Epub 2020 Nov 20.
8
Racial disparities in survival outcomes among breast cancer patients by molecular subtypes.
Breast Cancer Res Treat. 2021 Feb;185(3):841-849. doi: 10.1007/s10549-020-05984-w. Epub 2020 Oct 27.
9
Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
JAMA Netw Open. 2020 Oct 1;3(10):e2020303. doi: 10.1001/jamanetworkopen.2020.20303.
10
The tumor microenvironment of colorectal cancer metastases: opportunities in cancer immunotherapy.
Immunotherapy. 2020 Oct;12(14):1083-1100. doi: 10.2217/imt-2020-0026. Epub 2020 Aug 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验